Skip to main content

Table 2 Mean ± SEM apoptotic rate (percentage) in SLC22A18 transfected U251 cells

From: Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma

Group (n = 6)

24 h

48 h

Normal U251

1.95 ± 0.32

3.69 ± 0.19

U251-EV

1.95 ± 0.38

3.71 ± 0.21

U251-SLC22A18

25.25 ± 4.28

30.84 ± 4.72

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us